{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "30cedf05-9f61-4fff-b4ca-b17c2f627ce4",
   "metadata": {},
   "outputs": [],
   "source": [
    "# RAG - Types of Retriever in Lanchain V1"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "aa5b750f-6d7a-43e9-9499-30e71865225e",
   "metadata": {},
   "source": [
    "| ID | Text                            | Year | Type       |\n",
    "| -- | ------------------------------- | ---- | ---------- |\n",
    "| D1 | ‚ÄúAspirin treats pain and fever‚Äù | 2020 | medicine   |\n",
    "| D2 | ‚ÄúCancer drug improves survival‚Äù | 2023 | medicine   |\n",
    "| D3 | ‚ÄúAI detects cancer early‚Äù       | 2022 | technology |\n",
    "| D4 | ‚ÄúFDA approved new cancer drug‚Äù  | 2024 | regulation |\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "d96f5441-ddfc-44a7-80af-4b52db1162fd",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\15016\\AppData\\Local\\Temp\\ipykernel_11992\\1523852108.py:21: LangChainDeprecationWarning: The class `HuggingFaceEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the `langchain-huggingface package and should be used instead. To use it run `pip install -U `langchain-huggingface` and import as `from `langchain_huggingface import HuggingFaceEmbeddings``.\n",
      "  embeddings = HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\")\n",
      "C:\\Users\\15016\\anaconda3\\envs\\langchainai\\Lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vector Search:\n",
      "- FDA approved new cancer drug\n",
      "- Cancer drug improves survival\n"
     ]
    }
   ],
   "source": [
    "# üìö Docs\n",
    "from langchain_core.documents import Document\n",
    "\n",
    "docs = [\n",
    "    Document(page_content=\"Aspirin treats pain and fever\", metadata={\"year\": 2020, \"type\": \"medicine\"}),\n",
    "    Document(page_content=\"Cancer drug improves survival\", metadata={\"year\": 2023, \"type\": \"medicine\"}),\n",
    "    Document(page_content=\"AI detects cancer early\", metadata={\"year\": 2022, \"type\": \"technology\"}),\n",
    "    Document(page_content=\"FDA approved new cancer drug\", metadata={\"year\": 2024, \"type\": \"regulation\"}),\n",
    "]\n",
    "\n",
    "# üîê LLM\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langchain_openai import ChatOpenAI\n",
    "\n",
    "load_dotenv(\".env\")\n",
    "llm = ChatOpenAI(model=\"gpt-4o-mini\", temperature=0)\n",
    "\n",
    "# üß† FREE embeddings\n",
    "from langchain_community.embeddings import HuggingFaceEmbeddings\n",
    "embeddings = HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\")\n",
    "\n",
    "# üß† Vector DB\n",
    "from langchain_community.vectorstores import Chroma\n",
    "vectorstore = Chroma.from_documents(docs, embeddings)\n",
    "\n",
    "retriever = vectorstore.as_retriever(search_kwargs={\"k\": 2})\n",
    "\n",
    "print(\"Vector Search:\")\n",
    "for d in retriever.invoke(\"new cancer medicine\"):\n",
    "    print(\"-\", d.page_content)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a7df0375-5e5a-4304-ad2f-ba12a594a6ba",
   "metadata": {},
   "outputs": [],
   "source": [
    "Now the student asks:\n",
    "\n",
    "‚ÄúTell me about new cancer medicine‚Äù"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3ed61f52-b7e7-4633-b528-dbba6c074b74",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 1Ô∏è‚É£ VectorStoreRetriever\n",
    "\n",
    "(Meaning-based search)\n",
    "\n",
    "Like: Google but smarter\n",
    "\n",
    "It doesn‚Äôt match words.\n",
    "It matches meaning.\n",
    "\n",
    "Even if the question says\n",
    "‚Äúnew cancer medicine‚Äù\n",
    "it will find:\n",
    "\n",
    "‚úî ‚ÄúCancer drug improves survival‚Äù\n",
    "‚úî ‚ÄúFDA approved new cancer drug‚Äù\n",
    "\n",
    "Because embeddings understand that:\n",
    "\n",
    "medicine ‚âà drug\n",
    "new ‚âà recent\n",
    "\n",
    "Flow\n",
    "Question\n",
    "   ‚Üì\n",
    "Converted to numbers (embedding)\n",
    "   ‚Üì\n",
    "Compared with document embeddings\n",
    "   ‚Üì\n",
    "Most similar documents returned"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "1a0086f0-b2a2-474c-af15-ae31e6cc6b03",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vector Search:\n",
      "- FDA approved new cancer drug\n",
      "- Cancer drug improves survival\n"
     ]
    }
   ],
   "source": [
    "print(\"Vector Search:\")\n",
    "for d in retriever.invoke(\"Tell me about new cancer medicine\"):\n",
    "    print(\"-\", d.page_content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "352bfc5a-5cc6-4929-b672-819b885c03f3",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 2Ô∏è‚É£ MultiQueryRetriever\n",
    "\n",
    "(Ask in many ways)\n",
    "\n",
    "The LLM rewrites the question:\n",
    "\n",
    "User:\n",
    "\n",
    "‚Äúnew cancer medicine‚Äù\n",
    "\n",
    "LLM creates:\n",
    "\n",
    "‚ÄúWhat cancer drugs were recently released?‚Äù\n",
    "‚ÄúLatest FDA approved cancer drugs‚Äù\n",
    "‚ÄúNew treatment for cancer‚Äù\n",
    "\n",
    "\n",
    "Each one searches the vector DB.\n",
    "\n",
    "Then results are merged.\n",
    "\n",
    "So even if one phrasing misses D4,\n",
    "another will find it.\n",
    "\n",
    "This increases recall üìà"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "df92ce00-9cc5-41c1-8194-da0ff0d6019a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Generated queries:\n",
      "- new cancer treatment  \n",
      "- latest cancer drug  \n",
      "- recent cancer therapy\n"
     ]
    }
   ],
   "source": [
    "rewrite_prompt = \"\"\"\n",
    "Rewrite the following question into 3 different search queries\n",
    "that mean the same thing.\n",
    "\n",
    "Question: {q}\n",
    "\n",
    "Return only the queries, one per line.\n",
    "\"\"\"\n",
    "\n",
    "from langchain_core.prompts import PromptTemplate\n",
    "\n",
    "rewrite_chain = PromptTemplate.from_template(rewrite_prompt) | llm\n",
    "\n",
    "queries = rewrite_chain.invoke({\"q\": \"new cancer medicine\"}).content.split(\"\\n\")\n",
    "\n",
    "print(\"Generated queries:\")\n",
    "for q in queries:\n",
    "    print(\"-\", q)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c9c16927-77e9-4f0b-9db9-367d43fa11e6",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 3Ô∏è‚É£ SelfQueryRetriever\n",
    "\n",
    "(Smart filtering)\n",
    "\n",
    "User asks:\n",
    "\n",
    "‚ÄúFDA cancer drugs after 2022‚Äù\n",
    "\n",
    "LLM converts this into:\n",
    "\n",
    "type = \"medicine\"\n",
    "AND year > 2022\n",
    "AND text contains \"cancer\"\n",
    "\n",
    "\n",
    "Now it filters table:\n",
    "\n",
    "Text\tYear\tType\n",
    "Cancer drug improves survival\t2023\tmedicine\n",
    "FDA approved new cancer drug\t2024\tregulation\n",
    "\n",
    "Then vector search happens on only these.\n",
    "\n",
    "Perfect for compliance & audit."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "1438536a-3467-47f3-9c1b-441776225aa8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Vector Search:\n",
      "- FDA approved new cancer drug\n",
      "- FDA approved new cancer drug\n",
      "\n",
      "MultiQuery Results:\n",
      "- FDA approved new cancer drug\n",
      "\n",
      "Generated Filters:\n",
      "year > 2022  \n",
      "keyword = cancer drugs\n",
      "\n",
      "SelfQuery Results:\n",
      "- Cancer drug improves survival\n",
      "- FDA approved new cancer drug\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langchain_openai import ChatOpenAI\n",
    "from langchain_core.prompts import PromptTemplate\n",
    "from langchain_core.documents import Document\n",
    "from langchain_community.embeddings import HuggingFaceEmbeddings\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_community.retrievers import BM25Retriever\n",
    "from langchain_community.tools.tavily_search import TavilySearchResults\n",
    "\n",
    "\n",
    "# ------------------- Setup -------------------\n",
    "load_dotenv(\".env\")\n",
    "\n",
    "llm = ChatOpenAI(model=\"gpt-4o-mini\", temperature=0)\n",
    "embeddings = HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\")\n",
    "\n",
    "docs = [\n",
    "    Document(page_content=\"Aspirin treats pain and fever\", metadata={\"year\": 2020}),\n",
    "    Document(page_content=\"Cancer drug improves survival\", metadata={\"year\": 2023}),\n",
    "    Document(page_content=\"AI detects cancer early\", metadata={\"year\": 2022}),\n",
    "    Document(page_content=\"FDA approved new cancer drug\", metadata={\"year\": 2024}),\n",
    "]\n",
    "\n",
    "# Vector DB\n",
    "vectorstore = Chroma.from_documents(docs, embeddings)\n",
    "retriever = vectorstore.as_retriever(search_kwargs={\"k\": 2})\n",
    "\n",
    "# ------------------- 1Ô∏è‚É£ Vector Search -------------------\n",
    "print(\"\\nVector Search:\")\n",
    "for d in retriever.invoke(\"new cancer medicine\"):\n",
    "    print(\"-\", d.page_content)\n",
    "\n",
    "# ------------------- 2Ô∏è‚É£ MultiQuery -------------------\n",
    "rewrite_prompt = PromptTemplate.from_template(\n",
    "    \"Rewrite the question in 3 different ways:\\n{q}\"\n",
    ")\n",
    "\n",
    "queries = (rewrite_prompt | llm).invoke({\"q\": \"new cancer medicine\"}).content.split(\"\\n\")\n",
    "\n",
    "results = []\n",
    "for q in queries:\n",
    "    results += retriever.invoke(q)\n",
    "\n",
    "unique = {d.page_content: d for d in results}.values()\n",
    "\n",
    "print(\"\\nMultiQuery Results:\")\n",
    "for d in unique:\n",
    "    print(\"-\", d.page_content)\n",
    "\n",
    "# ------------------- 3Ô∏è‚É£ SelfQuery -------------------\n",
    "filter_prompt = PromptTemplate.from_template(\n",
    "    \"Extract filters.\\nOnly return:\\nyear > number\\nkeyword = word\\nQuestion: {q}\"\n",
    ")\n",
    "\n",
    "filters = (filter_prompt | llm).invoke(\n",
    "    {\"q\": \"FDA cancer drugs after 2022\"}\n",
    ").content\n",
    "\n",
    "print(\"\\nGenerated Filters:\")\n",
    "print(filters)\n",
    "\n",
    "filtered = []\n",
    "for d in docs:\n",
    "    if d.metadata[\"year\"] > 2022 and \"cancer\" in d.page_content.lower():\n",
    "        filtered.append(d)\n",
    "\n",
    "print(\"\\nSelfQuery Results:\")\n",
    "for d in filtered:\n",
    "    print(\"-\", d.page_content)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "57f4747a-af46-4074-80d5-94c3961449bc",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 4Ô∏è‚É£ ParentDocumentRetriever\n",
    "\n",
    "(Chunk ‚Üí full book)\n",
    "\n",
    "PDF example:\n",
    "\n",
    "Page 1: cancer\n",
    "Page 2: dosage\n",
    "Page 3: side effects\n",
    "\n",
    "User asks:\n",
    "\n",
    "‚ÄúWhat are side effects?‚Äù\n",
    "\n",
    "Retriever finds Page 3 (chunk)\n",
    "But returns the whole PDF\n",
    "\n",
    "So the LLM sees full context."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "cd9df4d0-9a82-4759-b1f1-7b117d292944",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "User: What are side effects?\n",
      "\n",
      "Returned full pages:\n"
     ]
    }
   ],
   "source": [
    "from langchain_core.documents import Document\n",
    "from langchain_community.embeddings import HuggingFaceEmbeddings\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "\n",
    "# -------------------------\n",
    "# 1. Fake PDF pages\n",
    "# -------------------------\n",
    "pages = [\n",
    "    Document(page_content=\"[pdf1_page1] Cancer is a disease caused by uncontrolled cell growth.\"),\n",
    "    Document(page_content=\"[pdf1_page2] Dosage depends on patient weight and age.\"),\n",
    "    Document(page_content=\"[pdf1_page3] Side effects include nausea, hair loss, and fatigue.\"),\n",
    "]\n",
    "\n",
    "# -------------------------\n",
    "# 2. Chunk them\n",
    "# -------------------------\n",
    "splitter = RecursiveCharacterTextSplitter(chunk_size=40, chunk_overlap=0)\n",
    "chunks = splitter.split_documents(pages)\n",
    "\n",
    "# -------------------------\n",
    "# 3. Vector DB\n",
    "# -------------------------\n",
    "embeddings = HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\")\n",
    "vectorstore = Chroma.from_documents(chunks, embeddings)\n",
    "retriever = vectorstore.as_retriever()\n",
    "\n",
    "# -------------------------\n",
    "# 4. Parent lookup\n",
    "# -------------------------\n",
    "parent_docs = {\n",
    "    \"pdf1_page1\": pages[0],\n",
    "    \"pdf1_page2\": pages[1],\n",
    "    \"pdf1_page3\": pages[2],\n",
    "}\n",
    "\n",
    "# -------------------------\n",
    "# 5. Ask a question\n",
    "# -------------------------\n",
    "print(\"User: What are side effects?\\n\")\n",
    "\n",
    "chunk_hits = retriever.invoke(\"What are side effects?\")\n",
    "\n",
    "# extract parent id from text\n",
    "parent_ids = set()\n",
    "for d in chunk_hits:\n",
    "    if \"[\" in d.page_content:\n",
    "        pid = d.page_content.split(\"]\")[0][1:]\n",
    "        parent_ids.add(pid)\n",
    "\n",
    "print(\"Returned full pages:\")\n",
    "for pid in parent_ids:\n",
    "    print(parent_docs[pid].page_content)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f4691d89-1334-4a37-80d2-2fe4a208ce78",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 5Ô∏è‚É£ EnsembleRetriever\n",
    "\n",
    "(Smart mix)\n",
    "\n",
    "Uses:\n",
    "\n",
    "‚Ä¢ Vector search (meaning)\n",
    "‚Ä¢ BM25 (keyword)\n",
    "\n",
    "So if user types:\n",
    "\n",
    "‚ÄúFDA‚Äù\n",
    "\n",
    "Keyword finds D4\n",
    "Meaning search finds D2\n",
    "\n",
    "Best of both worlds üî•"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "b035741c-c8c1-4bb0-beb1-51b16c181628",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Ensemble Results:\n",
      "- FDA approved new cancer drug\n",
      "- AI detects cancer early\n",
      "- Cancer drug improves survival\n",
      "- Aspirin treats pain and fever\n"
     ]
    }
   ],
   "source": [
    "# ------------------- 4Ô∏è‚É£ Ensemble -------------------\n",
    "bm25 = BM25Retriever.from_documents(docs)\n",
    "\n",
    "vector_results = retriever.invoke(\"FDA cancer\")\n",
    "bm25_results = bm25.invoke(\"FDA cancer\")\n",
    "\n",
    "combined = {d.page_content: d for d in vector_results + bm25_results}.values()\n",
    "\n",
    "print(\"\\nEnsemble Results:\")\n",
    "for d in combined:\n",
    "    print(\"-\", d.page_content)\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "69f57a04-7122-4045-a76c-ca37ca6cd406",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 6Ô∏è‚É£ TimeWeightedRetriever\n",
    "\n",
    "(Recent memory)\n",
    "\n",
    "If user keeps asking about cancer,\n",
    "and recently talked about FDA,\n",
    "\n",
    "D4 gets boosted\n",
    "\n",
    "So newer & frequent topics are preferred.\n",
    "\n",
    "Like your brain remembering recent topics üß†"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c2352531-a272-4c44-824d-fd044bb7a5cc",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b65eeb73-d887-413c-b9c1-8ad682d7608e",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 7Ô∏è‚É£ BM25Retriever\n",
    "\n",
    "(Classic keyword search)\n",
    "\n",
    "User types:\n",
    "\n",
    "‚ÄúFDA‚Äù\n",
    "\n",
    "Only documents with exact word FDA come.\n",
    "\n",
    "Finds:\n",
    "‚úî ‚ÄúFDA approved new cancer drug‚Äù\n",
    "\n",
    "No embeddings.\n",
    "Fast and accurate for legal, tables."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f27c27b2-5c87-42db-90e6-2f24c2b30fd1",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ebb631b2-a79e-4ddd-acad-79aaa1a2cbb8",
   "metadata": {},
   "outputs": [],
   "source": [
    "üß† 8Ô∏è‚É£ ContextualCompressionRetriever\n",
    "\n",
    "(Summarizer before LLM)\n",
    "\n",
    "It takes:\n",
    "\n",
    "‚ÄúFDA approved new cancer drug after trials‚Ä¶‚Äù\n",
    "\n",
    "and shrinks it to:\n",
    "\n",
    "‚ÄúFDA approved a new cancer drug in 2024.‚Äù\n",
    "\n",
    "So LLM gets only what matters.\n",
    "Less tokens, less hallucination."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "f0d2959b-601f-4192-8a88-2ce1f86e3549",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Retrieved Documents:\n",
      "- FDA approved new cancer drug\n",
      "- FDA approved new cancer drug\n",
      "- FDA approved new cancer drug\n",
      "- FDA approved new cancer drug\n",
      "\n",
      "Compressed Context:\n",
      "- The FDA has recently approved a new cancer drug, which is expected to provide new treatment options for patients. This approval signifies a significant advancement in cancer therapy, potentially improving outcomes for those affected by the disease. Further details about the drug's specific indications, efficacy, and safety profile may be available in the official announcement or accompanying documentation.\n",
      "- The FDA has recently approved a new cancer drug, which is expected to provide new treatment options for patients. This approval signifies a significant advancement in cancer therapy, potentially improving outcomes for those affected by the disease. Further details about the drug's specific indications, efficacy, and safety profile may be available in the official announcement or accompanying studies.\n",
      "- The FDA has recently approved a new cancer drug, which signifies a significant advancement in cancer treatment options. This approval may provide new hope for patients and could potentially improve outcomes in cancer therapy. Further details about the drug's specific indications, mechanism of action, and clinical trial results would provide additional context on its impact.\n",
      "- The FDA has recently approved a new cancer drug, which is expected to provide new treatment options for patients. This approval signifies a significant advancement in cancer therapy, potentially improving outcomes for those affected by the disease. Further details about the drug's specific indications, efficacy, and safety profile may be available in the official announcement or accompanying documentation.\n",
      "\n",
      "Final Answer:\n",
      "The FDA recently approved a new cancer drug, which is expected to provide new treatment options for patients and signifies a significant advancement in cancer therapy, potentially improving outcomes for those affected by the disease.\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langchain_openai import ChatOpenAI\n",
    "from langchain_core.prompts import PromptTemplate\n",
    "from langchain_core.documents import Document\n",
    "from langchain_community.embeddings import HuggingFaceEmbeddings\n",
    "from langchain_community.vectorstores import Chroma\n",
    "\n",
    "# ------------------------\n",
    "# Setup\n",
    "# ------------------------\n",
    "load_dotenv(\".env\")\n",
    "\n",
    "llm = ChatOpenAI(model=\"gpt-4o-mini\", temperature=0)\n",
    "\n",
    "# ------------------------\n",
    "# Documents (long text)\n",
    "# ------------------------\n",
    "docs = [\n",
    "    Document(page_content=\"FDA approved a new cancer drug after multiple clinical trials showed improved survival and fewer side effects.\"),\n",
    "    Document(page_content=\"Cancer drug research has increased significantly in recent years, with many therapies entering late-stage trials.\"),\n",
    "]\n",
    "\n",
    "# ------------------------\n",
    "# Vector DB\n",
    "# ------------------------\n",
    "embeddings = HuggingFaceEmbeddings(model_name=\"all-MiniLM-L6-v2\")\n",
    "vectorstore = Chroma.from_documents(docs, embeddings)\n",
    "retriever = vectorstore.as_retriever()\n",
    "\n",
    "# ------------------------\n",
    "# User query\n",
    "# ------------------------\n",
    "query = \"new FDA cancer drug\"\n",
    "\n",
    "found_docs = retriever.invoke(query)\n",
    "\n",
    "print(\"Retrieved Documents:\")\n",
    "for d in found_docs:\n",
    "    print(\"-\", d.page_content)\n",
    "\n",
    "# ------------------------\n",
    "# Contextual Compression\n",
    "# ------------------------\n",
    "compress_prompt = PromptTemplate.from_template(\n",
    "    \"Summarize this for answering the question:\\n{doc}\"\n",
    ")\n",
    "\n",
    "compressed_docs = []\n",
    "\n",
    "for d in found_docs:\n",
    "    summary = (compress_prompt | llm).invoke({\"doc\": d.page_content}).content\n",
    "    compressed_docs.append(summary)\n",
    "\n",
    "print(\"\\nCompressed Context:\")\n",
    "for c in compressed_docs:\n",
    "    print(\"-\", c)\n",
    "\n",
    "# ------------------------\n",
    "# Final Answer\n",
    "# ------------------------\n",
    "final_context = \"\\n\".join(compressed_docs)\n",
    "\n",
    "final_prompt = PromptTemplate.from_template(\n",
    "    \"Use the following compressed context to answer:\\n{context}\\n\\nQuestion: {q}\"\n",
    ")\n",
    "\n",
    "answer = (final_prompt | llm).invoke({\n",
    "    \"context\": final_context,\n",
    "    \"q\": \"What did the FDA do about cancer drugs?\"\n",
    "})\n",
    "\n",
    "print(\"\\nFinal Answer:\")\n",
    "print(answer.content)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "46b04c91-de56-4a42-9c43-3a1af5741248",
   "metadata": {},
   "outputs": [],
   "source": [
    "üåê Tavily (Live Web Search)\n",
    "\n",
    "Now suppose user asks:\n",
    "\n",
    "‚ÄúLatest cancer drug news today‚Äù\n",
    "\n",
    "Your vector DB is old.\n",
    "\n",
    "So Tavily does:\n",
    "\n",
    "Search internet\n",
    "   ‚Üì\n",
    "Get live articles\n",
    "   ‚Üì\n",
    "Pass to LLM\n",
    "\n",
    "\n",
    "So RAG becomes:\n",
    "\n",
    "Vector DB (internal)\n",
    " + Tavily (internet)\n",
    " ‚Üí Best answer\n",
    "\n",
    "\n",
    "This is how ChatGPT stays current üîç\n",
    "\n",
    "üß© Final Big Picture\n",
    "User Question\n",
    "   ‚Üì\n",
    "Retriever (one or many)\n",
    "   ‚Üì\n",
    "Relevant documents\n",
    "   ‚Üì\n",
    "(Optional) Tavily Web Search\n",
    "   ‚Üì\n",
    "Context to LLM\n",
    "   ‚Üì\n",
    "Final Answer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "13f2a4b8-4e64-46f8-a2fe-320e2ecddc39",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Tavily (Live Web):\n",
      "[{'title': 'MSK-Led Research Resulted in New FDA Approvals for Cancer ...', 'url': 'https://www.mskcc.org/news/msk-led-research-resulted-in-11-new-fda-approvals-for-cancer-drugs-in-2025', 'content': 'By\\nJulie Grisham\\nMonday, December 15, 2025\\n\\nMSK patient Ellen Coopersmith smiling in a rowboat in Central Park\\n\\nThe U.S. Food and Drug Administration (FDA) approved 10 cancer drugs in 2025, based on clinical trials in which MSK played a pivotal role.\\n\\nThese approvals spanned therapies for a range of solid tumors and blood cancers and included treatments for both common and rare types of tumors. They are listed in chronological order.\\n\\n(Note:\\u202fThe FDA uses the term ‚Äúaccelerated approval‚Äù for drugs that treat diseases lacking effective treatments. These criteria are slightly different from a standard approval. The term ‚Äúfull approval‚Äù applies to drugs that had previously been granted ‚Äúconditional approval.‚Äù)\\n\\n## Sarcoma [...] Read more.\\n\\n## Lung Cancer\\n\\nFor adults with advanced small cell lung cancer that has spread after\\u202fplatinum-based chemotherapy, the FDA granted full approval on\\u202fNovember 19 to tarlatamab (Imdelltra¬Æ), a targeted immunotherapy drug. The approval was based on an international phase 3 clinical trial led by MSK scientist and thoracic medical oncologist Charles Rudin, MD, PhD. Tarlatamab\\u202freceived accelerated approval from the FDA in May 2024, based on results from a phase 2 trial.\\n\\nRead more.\\n\\n## Gastric Cancer [...] ## Sarcoma\\n\\nFor adults with a rare\\u202fcondition called\\u202ftenosynovial giant cell tumor (TGCT), the FDA approved vimseltinib (RomvimzaTM) on February 14. Sarcoma oncologist William Tap, MD, Chief of the Sarcoma Medical Oncology Service at MSK, led the international phase 3 trial that resulted in the drug‚Äôs approval. Vimseltinib is a type of targeted therapy called a kinase inhibitor. TGCT, which is also called pigmented villonodular synovitis, is a tumor of the tissue that lines the joints.\\n\\nRead more.\\n\\n## Prostate Cancer', 'score': 0.7634314}, {'title': 'Oncology (Cancer)/Hematologic Malignancies Approval Notifications', 'url': 'https://www.fda.gov/drugs/resources-information-approved-drugs/oncology-cancerhematologic-malignancies-approval-notifications', 'content': '| FDA grants accelerated approval to zanubrutinib for relapsed or refractory follicular lymphoma | On March 7, 2024, the Food and Drug Administration granted accelerated approval to zanubrutinib (Brukinsa, BeiGene USA, Inc.) with obinutuzumab for relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. | 3/7/2024 |\\n| FDA approves nivolumab in combination with cisplatin and gemcitabine for unresectable or metastatic urothelial carcinoma | On March 6, 2024, the Food and Drug Administration approved nivolumab (Opdivo, Bristol-Myers Squibb Company) in combination with cisplatin and gemcitabine for first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma (UC). | 3/7/2024 | [...] | FDA approves tepotinib for metastatic non-small cell lung cancer | On February 15, 2024, the Food and Drug Administration granted traditional approval to tepotinib (Tepmetko, EMD Serono, Inc.) for adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations. | 2/15/2024 |\\n| FDA approves irinotecan liposome for first-line treatment of metastatic pancreatic adenocarcinoma | On February 13, 2024, the Food and Drug Administration approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) with oxaliplatin, fluorouracil, and leucovorin, for the first-line treatment of metastatic pancreatic adenocarcinoma. | 2/13/2024 | [...] | FDA approves obecabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia | On November 8, 2024, the Food and Drug Administration approved obecabtagene autoleucel (Aucatzyl, Autolus Inc.), a CD19-directed genetically modified autologous T cell immunotherapy, for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). | 11/8/2024 |\\n| FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia | On October 29, 2024, the Food and Drug Administration granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). | 10/29/2024 |', 'score': 0.7213709}, {'title': '2025 FDA approvals - Nature', 'url': 'https://www.nature.com/articles/d41573-026-00001-z', 'content': 'Pembrolizumab is forecasted to pull in around $32 billion in 2025, making it the top-selling cancer drug (and third-highest selling drug overall). Analysts at Evaluate expect the subcutaneous product to contribute $9.3 billion in peak sales.\\n\\nAkeso Biopharma secured an approval for its PD1 blocker penpulimab (Penpulimab), bringing the number of available PD1/PDL1 antibodies up to 12.\\n\\n2025 also saw the approval of two new antibody‚Äìdrug conjugates (ADCs), a modality made up of tissue-selective antibodies fused to potent cell-killing drugs. Daiichi Sankyo‚Äôs TROP2-targeted ADC datopotamab deruxtecan (Datroway) secured a thumbs up for the treatment of hormone receptor-positive, HER2-negative breast cancer following endocrine-based therapy and chemotherapy. [...] More changes could be coming. The FDA typically requires drug developers to run two pivotal trials to secure full approvals for their products, but the agency is reportedly moving towards making the default requirement a single trial.\\n\\n## The cancer crowd\\n\\nCancer continues to dominate industry‚Äôs pipeline. But while oncology drugs contribute the bulk of the new approvals, they account for just two multi-blockbuster drugs, with earning potential of over $2 billion annually according to Evaluate forecasts.\\n\\nThe top-selling new approval is likely to be Merck & Co.‚Äôs subcutaneous formulation of pembrolizumab plus berahyaluronidase alfa (Keytruda Qlex) for various solid tumours. [...] | Drug name | Sponsor | Properties | Indication | Timing |\\n ---  --- \\n| Clemidsogene lanparvovec | Regenxbio | Gene therapy, AAV9 vector and IDS transgene | Hunter syndrome | February |\\n| Orforgliprona | Eli Lilly | Small-molecule oral GLP-1 receptor agonist | Obesity | March? |\\n| Tividenofusp alfab | Denali | Enzyme replacement therapy; IDS fused to a BBB shuttle | Hunter syndrome | April |\\n| Vusolimogene oderparepvecb | Replimune | Oncolytic virus | Cancer | April |\\n| Vepdegestrant | Arvinas/Pfizer | Oestrogen receptor degrading PROTAC | Cancer | June |\\n| Enlicitidea | Merck & Co. | Small-molecule oral PCSK9 inhibitor | Lipid lowering | 1H2026? |\\n| Camizestrantb | AstraZeneca | Selective oestrogen receptor degrader | Cancer | 1H2026 |', 'score': 0.60386235}, {'title': 'Q1 2026: 5 FDA Decisions to Watch in the Realm of Oncology', 'url': 'https://www.onclive.com/view/q1-2026-5-fda-decisions-to-watch-in-the-realm-of-oncology', 'content': 'On July 9, 2025, Taiho Oncology announced that the FDA accepted for review a supplemental new drug application (NDA) for decitabine and cedazuridine (Inqovi) plus venetoclax (Venclexta) for adult patients with newly diagnosed acute myeloid leukemia (AML) who are ineligible for intensive induction chemotherapy.4 Based on findings from the phase 2b ASCERTAIN-V trial (NCT04657081), the all-oral regimen achieved a complete response (CR) rate of 46.5% and a complete response (CR)/CR with incomplete hematologic recovery rate of 63.4% at a median follow-up of 11.2 months, with durable responses observed across key subgroups. The submission follows presentations of the data at the 2025 ASCO Annual Meeting and the 2025 EHA Congress. [...] According to a Merck news release, this application is notable as pembrolizumab represents the first immunotherapy to demonstrate an OS benefit in certain patients with platinum-resistant recurrent ovarian cancer, a setting with historically limited treatment options.\\n\\n## #3: Decitabine/Cedazuridine Plus Venetoclax\\n\\nDrug Indication: Newly Diagnosed AML  \\nProjected Action Date: February 25, 2026 [...] According to a Taiho Oncology news release, this application is significant because it could introduce the first fully oral frontline treatment option for patients with AML who are unable to receive intensive chemotherapy.\\n\\n## #4: Piflufolastat F 18\\n\\nIndication: PSMA-PET Imaging in Prostate Cancer  \\nProjected Action Date: March 6, 2026', 'score': 0.5954225}, {'title': 'FDA approves first cancer drug based on Broad Institute science', 'url': 'https://www.broadinstitute.org/news/fda-approves-first-cancer-drug-based-broad-institute-science', 'content': '### Related\\n\\nHuman cells with acute myelocytic leukemia (AML) in the pericardial fluid. in the pericardial fluid.\")\\nThe SHOC2-MRAS-PP1C complex is made up of three proteins that regulate the RAS signaling pathway and help cancer cells with RAS mutations survive.\\nAlex Burgin and Flo Wagner\\nAllison Dougherty, Broad Communications\\nFlorence Wagner, who spoke about drug repurposing at a public talk at the Broad in November 2019, is collaborating with scientists involved in COVID-19 therapeutics research.\\n\\n### Latest news [...] A Phase III clinical trial is continuing to evaluate sevabertinib as a first-line treatment option for patients with NSCLC carrying HER2 mutations. The drug is also being studied in patients with other metastatic or unresectable solid tumors, beyond lung cancer, that have HER2 mutations.\\n\\n\"We\\'re in an extraordinary time for the development of new medicines to treat cancer patients,\" said Meyerson. \"And I think that, with our industry partners, we have a huge opportunity to repeat this success not once, not twice, but many, many times over.\"\\n\\n### Related', 'score': 0.5928793}]\n"
     ]
    }
   ],
   "source": [
    "# ------------------- 5Ô∏è‚É£ Tavily -------------------\n",
    "tavily = TavilySearchResults()\n",
    "\n",
    "print(\"\\nTavily (Live Web):\")\n",
    "print(tavily.invoke(\"latest cancer drug news\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ac5515bd-7d54-4054-aa5e-785a03d536de",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python (langchainai)",
   "language": "python",
   "name": "langchainai"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
